SLC2A1 and neoplasm: This overexpression correlates with poor prognosis, radiotherapy resistance, enhanced glycolysis and hypoxia within the tumour microenvironment, as evidenced by positive associations between LDHA expression and markers such as HIF1A and GLUT-1.